Company Details
eurofins
25,341
616,436
541714
eurofins.com
90
EUR_1422152
Completed

Eurofins Company CyberSecurity Posture
eurofins.comSince 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.
Company Details
eurofins
25,341
616,436
541714
eurofins.com
90
EUR_1422152
Completed
Between 750 and 799

Eurofins Global Score (TPRM)XXXX



No incidents recorded for Eurofins in 2025.
No incidents recorded for Eurofins in 2025.
No incidents recorded for Eurofins in 2025.
Eurofins cyber incidents detection timeline including parent company and subsidiaries

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.


A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in v

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals w
Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development an

Biocon: Enhancing Global Healthcare Biocon Limited, publicly listed in 2004, is India's largest and fully-integrated, innovation-led biopharmaceutical company. It is an emerging global biopharmaceutical enterprise serving customers in over 120 countries. Driven by a vision to enhance global heal
CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our pr

At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all
Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality
At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy healt
.png)
Clinical Diagnostics paid millions in ransom after 485000 patient files were hacked. Nova criminals published only part of 300GB of data.
Personal health data from more than 485000 women has been stolen from a cervical cancer screening programme in the Netherlands.
Hackers steal data from 485000 women at a laboratory that conducts cervical cancer screening. Test results remain reliable.
Medfiles Ltd, a renowned contract research organization in Finland, announced the successful completion of the sale of its R&D and Analytical service...
Eurofins MET Labs is proud to announce the completion of a half-million-dollar expansion of its 10-meter EMC Chamber at their Santa Clara...
Pictured is Dhruv Bisani, Eurofins Cyber Security's (Commissum) Head of Red Team, who writes of red teaming as a defence tactic against...
Eurofins Scientific has agreed to offload its Digital Testing business to Stirling Square Capital Partners in a 220 million deal.
We have advised Eurofins Scientific (EUFI.PA), the global leader in food testing and a global scientific leader in bioanalytical testing,...
Global law firm White & Case LLP has advised investment management firm Barings on a unitranche financing for Stirling Square's acquisition...

Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
The official website of Eurofins is https://www.eurofins.com.
According to Rankiteo, Eurofins’s AI-generated cybersecurity score is 783, reflecting their Fair security posture.
According to Rankiteo, Eurofins currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
According to Rankiteo, Eurofins is not certified under SOC 2 Type 1.
According to Rankiteo, Eurofins does not hold a SOC 2 Type 2 certification.
According to Rankiteo, Eurofins is not listed as GDPR compliant.
According to Rankiteo, Eurofins does not currently maintain PCI DSS compliance.
According to Rankiteo, Eurofins is not compliant with HIPAA regulations.
According to Rankiteo,Eurofins is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Eurofins operates primarily in the Biotechnology Research industry.
Eurofins employs approximately 25,341 people worldwide.
Eurofins presently has no subsidiaries across any sectors.
Eurofins’s official LinkedIn profile has approximately 616,436 followers.
Eurofins is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).
Yes, Eurofins has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/eurofins.
Yes, Eurofins maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/eurofins.
As of December 11, 2025, Rankiteo reports that Eurofins has not experienced any cybersecurity incidents.
Eurofins has an estimated 4,470 peer or competitor companies worldwide.
Total Incidents: According to Rankiteo, Eurofins has faced 0 incidents in the past.
Incident Types: The types of cybersecurity incidents that have occurred include .
.png)
FreePBX Endpoint Manager is a module for managing telephony endpoints in FreePBX systems. Versions prior to 16.0.96 and 17.0.1 through 17.0.9 have a weak default password. By default, this is a 6 digit numeric value which can be brute forced. (This is the app_password parameter). Depending on local configuration, this password could be the extension, voicemail, user manager, DPMA or EPM phone admin password. This issue is fixed in versions 16.0.96 and 17.0.10.
Neuron is a PHP framework for creating and orchestrating AI Agents. In versions 2.8.11 and below, the MySQLWriteTool executes arbitrary SQL provided by the caller using PDO::prepare() + execute() without semantic restrictions. This is consistent with the name (“write tool”), but in an LLM/agent context it becomes a high-risk capability: prompt injection or indirect prompt manipulation can cause execution of destructive queries such as DROP TABLE, TRUNCATE, DELETE, ALTER, or privilege-related statements (subject to DB permissions). Deployments that expose an agent with MySQLWriteTool enabled to untrusted input and/or run the tool with a DB user that has broad privileges are impacted. This issue is fixed in version 2.8.12.
Neuron is a PHP framework for creating and orchestrating AI Agents. Versions 2.8.11 and below use MySQLSelectTool, which is vulnerable to Read-Only Bypass. MySQLSelectTool is intended to be a read-only SQL tool (e.g., for LLM agent querying, however, validation based on the first keyword (e.g., SELECT) and a forbidden-keyword list does not block file-writing constructs such as INTO OUTFILE / INTO DUMPFILE. As a result, an attacker who can influence the tool input (e.g., via prompt injection through a public agent endpoint) may write arbitrary files to the DB server if the MySQL/MariaDB account has the FILE privilege and server configuration permits writes to a useful location (e.g., a web-accessible directory). This issue is fixed in version 2.8.12.
Okta Java Management SDK facilitates interactions with the Okta management API. In versions 11.0.0 through 20.0.0, race conditions may arise from concurrent requests using the ApiClient class. This could cause a status code or response header from one request’s response to influence another request’s response. This issue is fixed in version 20.0.1.
The Auth0 Next.js SDK is a library for implementing user authentication in Next.js applications. When using versions 4.11.0 through 4.11.2 and 4.12.0, simultaneous requests on the same client may result in improper lookups in the TokenRequestCache for the request results. This issue is fixed in versions 4.11.2 and 4.12.1.

Get company history
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.